cetylpyridinium chloride anhydrous has been researched along with Carcinoma, Renal Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, C; Di Natale, C; Dörrschuck, A; Gesualdo, L; Glückmann, M; Herr, W; Huber, C; Karas, M; Lennerz, V; Lifke, A; Ranieri, E; Schmidt, A; Schnürer, E; Wölfel, C; Wölfel, T | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Carcinoma, Renal Cell
| Article | Year |
|---|---|
CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression.
Topics: Amino Acid Sequence; Antigens, Neoplasm; Carcinoma, Renal Cell; CD4-Positive T-Lymphocytes; Cell Separation; Colonic Neoplasms; Cross Reactions; Cytotoxicity, Immunologic; Epithelium; Epitopes; Flow Cytometry; Genotype; Health; Hematopoietic Stem Cells; Histocompatibility Antigens Class I; Humans; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Peptides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation, Homologous | 2004 |